Skip to Main Content

Author Details

Ryan A Metcalf
University of Utah
2010
48
13
PMIDPaper TitleJournal TitlePublished Year
36371753Bacterial culture time to detection in platelet components: An evidence synthesis and estimation of detection failures.Transfusion2023
37589199Meta-analysis of bacterial growth characteristics in platelet components: Refining the inputs of a simulation analysis comparing the relative safety of testing strategies.Transfusion2023
37403547Current advances in 2022: A critical review of selected topics by the Association for the Advancement of Blood and Biotherapies (AABB) Clinical Transfusion Medicine Committee.Transfusion2023
36420793The epidemiology of transfusion-related acute lung injury: A scoping review and analysis.Transfusion2023
36730468Antibody Titers in Transfusion Medicine: A Critical Reevaluation of Testing Accuracy, Reliability, and Clinical Use.Arch Pathol Lab Med2023
35079127Development and validation of a machine learning method to predict intraoperative red blood cell transfusions in cardiothoracic surgery.Sci Rep2022
35352362How do I implement an outpatient program for the administration of convalescent plasma for COVID-19?Transfusion2022
35713186Current advances in transfusion medicine 2021: A critical review of selected topics by the AABB Clinical Transfusion Medicine Committee.Transfusion2022
35969859Clinical Practice Guidelines From the Association for the Advancement of Blood and Biotherapies (AABB): COVID-19 Convalescent Plasma.Ann Intern Med2022
35912900Life threatening platelet transfusion refractoriness due to an anamnestic human leukocyte antigen alloantibody response.Transfusion2022
32996621The incremental benefit of anaerobic culture for controlling bacterial risk in platelets: a systematic review and meta-analysis.Vox Sang2021
33743799Passive Immunity Trial for Our Nation (PassITON): study protocol for a randomized placebo-control clinical trial evaluating COVID-19 convalescent plasma in hospitalized adults.Trials2021
33720316Heterogeneity in Approaches for Switching From Universal to Patient ABO Type-Specific Blood Components During Massive Hemorrhage.Arch Pathol Lab Med2021
33627023Classic Hodgkin lymphoma in Guatemalan children of age less than six years: analysis of immune regulatory pathways and the tumor microenvironment.Leuk Lymphoma2021
33586160COVID-19 convalescent plasma: Interim recommendations from the AABB.Transfusion2021
33688640Passive Immunity Trial for Our Nation (PassITON): study protocol for a randomized placebo-control clinical trial evaluating COVID-19 convalescent plasma in hospitalized adults.Res Sq2021
33831228In reply: Window periods for secondary bacterial culture of platelets according to FDA guidance.Transfusion2021
34423446Current advances in transfusion medicine 2020: A critical review of selected topics by the AABB Clinical Transfusion Medicine Committee.Transfusion2021
34619726Transfusion Preparedness in the Labor and Delivery Unit: An Initiative to Improve Safety and Cost.Obstet Gynecol2021
34158212Platelet Component False Positive Detection Rate in Aerobic and Anaerobic Primary Culture: A Systematic Review and Meta-Analysis.Transfus Med Rev2021
33429466The impact of the sample time of secondary bacterial culture on the risk of exposure to contaminated platelet components: A mathematical analysis.Transfusion2021
33438332Electronic clinical decision support: Evidence that default settings influence end-user behavior.Transfusion2021
32472580Current advances in transfusion medicine: a 2019 review of selected topics from the AABB Clinical Transfusion Medicine Committee.Transfusion2020
33031540Successful transfer of anti-SARS-CoV-2 immunity using convalescent plasma in an MM patient with hypogammaglobulinemia and COVID-19.Blood Adv2020
32632927The comparative safety of bacterial risk control strategies for platelet components: a simulation study.Transfusion2020
32757411Residual bacterial detection rates after primary culture as determined by secondary culture and rapid testing in platelet components: A systematic review and meta-analysis.Transfusion2020
32118560Things We Do for No Reasonâ¿¢: Routinely Prescribing Transfusion Premedication to Prevent Acute Transfusion Reactions.J Hosp Med2020
32181889Bacterial contamination rate of platelet components by primary culture: a systematic review and meta-analysis.Transfusion2020
30592057Evaluating safety and cost-effectiveness of platelets stored in additive solution (PAS-F) as a hemolysis risk mitigation strategy.Transfusion2019
30044350Severe ABO Hemolytic Disease of the Newborn Requiring Exchange Transfusion.J Pediatr Hematol Oncol2019
30950087Severe intravascular hemolysis following extracorporeal right ventricular assist device placement.Transfusion2019
31032968Response to random apheresis platelets versus HLA-selected platelets versus pooled platelets in HLA-sensitized patients.Transfusion2019
31106447The association of inpatient blood utilization and diagnosis-related group weight: implications for risk-adjusted benchmarking.Transfusion2019
30488953Transfusion-associated chest pain.Transfusion2019
29238996Quality management of a massive transfusion protocol.Transfusion2018
29359471A high plasma: red blood cell transfusion ratio during liver transplantation is associated with decreased blood utilization.Vox Sang2018
29462235Quality Improvement After Multiple Fatal Transfusion-Transmitted Bacterial Infections.Am J Clin Pathol2018
29714029A data-driven patient blood management strategy in liver transplantation.Vox Sang2018
29315627Transfusion support for transgender men of childbearing age.Transfusion2018
28898986Building a New Transfusion Service.Am J Clin Pathol2017
27284999Clinical Pattern in Hypotensive Transfusion Reactions.Anesth Analg2016
27357292Transportation Cooler Interventions Reduce Plasma and RBC Product Wastage.Am J Clin Pathol2016
25456392Large B-cell lymphoma with T-cell-rich background and nodules lacking follicular dendritic cell meshworks: description of an insufficiently recognized variant.Hum Pathol2015
26410017Immunoarchitectural patterns of progressive transformation of germinal centers with and without nodular lymphocyte-predominant Hodgkin lymphoma.Hum Pathol2015
24925224Myeloid cell nuclear differentiation antigen is expressed in a subset of marginal zone lymphomas and is useful in the differential diagnosis with follicular lymphoma.Hum Pathol2014
23480896Intravascular ALK-negative anaplastic large cell lymphoma with localized cutaneous involvement and an indolent clinical course: toward recognition of a distinct clinicopathologic entity.Am J Surg Pathol2013
22929040Cyclin D3 coordinates the cell cycle during differentiation to regulate erythrocyte size and number.Genes Dev2012
20062012Characterization of D-cyclin proteins in hematolymphoid neoplasms: lack of specificity of cyclin-D2 and D3 expression in lymphoma subtypes.Mod Pathol2010
  • 1 - 48 of 48

Recommended Authors

University of Texas Southwestern Medical Center
Career Start Year 2018
Number of shared co-authors 3
Yale University School of Medicine
Career Start Year 2015
Number of shared co-authors 4
Veterans Affairs Connecticut Healthcare System
Career Start Year 2014
Number of shared co-authors 1
Royal Children's Hospital
Career Start Year 2011
Number of shared co-authors 2
Mayo Clinic
Career Start Year 2009
Number of shared co-authors 10
Mayo Clinic
Career Start Year 2009
Number of shared co-authors 10
Children's National Hospital
Career Start Year 2009
Number of shared co-authors 1
Stanford University School of Medicine
Career Start Year 2008
Number of shared co-authors 2
Yale University School of Medicine, Yale-New Haven Hospital
Career Start Year 2007
Number of shared co-authors 3
Johns Hopkins University
Career Start Year 2007
Number of shared co-authors 13
University of Amsterdam
Career Start Year 2006
Number of shared co-authors 1
University of Pittsburgh Medical Center
Career Start Year 2004
Number of shared co-authors 4
Children's National Hospital
Career Start Year 2003
Number of shared co-authors 15
Columbia University Irving Medical Center, New York-Presbyterian Hospital
Career Start Year 2002
Number of shared co-authors 3
Emory University School of Medicine
Career Start Year 2001
Number of shared co-authors 9
Universite de Bretagne Occidentale, Centre Hospitalo-Universitaire de Brest
Career Start Year 2000
Number of shared co-authors 1
Columbia University Irving Medical Center, New York-Presbyterian Hospital
Career Start Year 2000
Number of shared co-authors 10
Mayo Clinic
Career Start Year 2000
Number of shared co-authors 4
University Health Network
Career Start Year 1996
Number of shared co-authors 2
RAND Corporation
Career Start Year 1995
Number of shared co-authors 9
Jon J van Rood Center for Clinical Transfusion Research
Career Start Year 1994
Number of shared co-authors 7
University of Oxford
Career Start Year 1992
Number of shared co-authors 8
USA Carver College of Medicine
Career Start Year 1992
Number of shared co-authors 11
Vitalant Research Institute
Career Start Year 1991
Number of shared co-authors 11
Mayo Clinic
Career Start Year 1991
Number of shared co-authors 13
University of Pittsburgh
Career Start Year 1990
Number of shared co-authors 7
Clinical Center, National Institutes of Health
Career Start Year 1974
Number of shared co-authors 4
Johns Hopkins University
Career Start Year 1974
Number of shared co-authors 8
University of Rochester Medical Center
Career Start Year 1974
Number of shared co-authors 2
University of Pittsburgh
Career Start Year 1871
Number of shared co-authors 3

Collaborators

University of New Mexico
Co-authored papers 9
University of Minnesota
Co-authored papers 8
Harborview Medical Center
Co-authored papers 5
Vanderbilt University Medical Center
Co-authored papers 4
Johns Hopkins University School of Medicine
Co-authored papers 3
Johns Hopkins University School of Medicine
Co-authored papers 3
Christian Medical College
Co-authored papers 3
Icahn School of Medicine at Mount Sinai
Co-authored papers 3
Johns Hopkins Bloomberg School of Public Health
Co-authored papers 3
LSU Health Sciences Center/Our Lady of the Lake Regional Medical Center
Co-authored papers 2
University of Washington
Co-authored papers 2
Vanderbilt University Medical Center
Co-authored papers 2
University of Chicago Medical Center
Co-authored papers 2
University of New Mexico School of Medicine
Co-authored papers 2
University of Utah Health
Co-authored papers 2
Rochester General Hospital
Co-authored papers 2
University of Arkansas for Medical Sciences
Co-authored papers 2
Marcus Center for Cellular Cures, Duke University
Co-authored papers 2
The Ohio State University Wexner Medical Center
Co-authored papers 2
Vanderbilt University Medical Center
Co-authored papers 2
State University of New York at Buffalo
Co-authored papers 2
Louisiana State University Health Sciences Center.
Co-authored papers 2
Duke University
Co-authored papers 2
University of Colorado School of Medicine
Co-authored papers 2
University of Maryland School of Medicine
Co-authored papers 2
Vanderbilt University Medical Center
Co-authored papers 2
Cleveland Clinic
Co-authored papers 2
University of Utah
Co-authored papers 2
Vanderbilt University School of Medicine
Co-authored papers 2
University of Mississippi Medical Center
Co-authored papers 2